1. |
Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med, 1965, 38:241-256.
|
2. |
Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology, 2013, 145(6):1215-1229.
|
3. |
孙学军, 郑见宝, 贺赛. 肝门部胆管癌的外科治疗及预后影响因素分析. 中国普外基础与临床杂志, 2014, 21(3):273-277.
|
4. |
Zhimin G, Noor H, Jian-Bo Z, et al. Advances in diagnosis and treatment of hilar cholangiocarcinoma-a review. Med Sci Monit, 2013, 19:648-656.
|
5. |
Suarez-Munoz MA, Fernandez-Aguilar JL, Sanchez-Perez B, et al. Risk factors and classifications of hilar cholangiocarcinoma. World J Gastrointest Oncol, 2013, 5(7):132-138.
|
6. |
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol, 2013, 28(4):593-607.
|
7. |
石力, 汤礼军, 汪涛, 等. 胆道金属支架置入治疗肝门部胆管癌的临床研究. 中国普通外科杂志, 2012, 21(8):918-921.
|
8. |
杨屹, 纪宗正, 吴涛, 等. PTCD 在肝门部胆管癌治疗中的临床作用(附67例报道). 中国普外基础与临床杂志, 2014, 21(3):285-288.
|
9. |
Kawakubo K, Kawakami H, Kuwatani M, et al. Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholan-giocarcinoma. World J Gastrointest Endosc, 2016, 8(9):385-390.
|
10. |
刘训强, 陈宦君, 王家平, 等. PTCD治疗阻塞性黄疸438例的临床疗效观察. 昆明医科大学学报, 2014, 35(6):51-54.
|
11. |
徐川, 施海彬, 刘圣, 等. 肝门部胆管癌致梗阻性黄疸介入引流治疗的预后分析. 介入放射学杂志, 2012, 21(9):752-755.
|
12. |
Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resec-tion and liver transplantation for intrahepatic and hilar cholangiocar-cinoma:a 24-year experience in a single center. Arch Surg, 2011, 146 (6):683-689.
|
13. |
Groeschl RT, Nagorney DM. Portal vein reconstruction during surgery for cholangiocarcinoma. Curr Opin Gastroenterol, 2016, 32 (3):216-224.
|
14. |
Schmelzle M, Sucher R, Seehofer D, et al. Regarding:impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma. Surgery, 2016, 159(3):986-987.
|
15. |
Mantel HT, Westerkamp AC, Adam R, et al. Strict selection alone of patients undergoing liver transplantation for hilar cholangiocar-cinoma is associated with improved survival. PLoS One, 2016, 11(6):e0156127.
|
16. |
van Gulik TM, Ruys AT, Busch OR, et al. Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor):how much is enough? Dig Surg, 2011, 28(2):141-147.
|
17. |
王春, 陈哲宇, 曾勇, 等. Ⅳ型肝门部胆管癌的治疗体会. 中国普外基础与临床杂志, 2012, 19(1):62-65.
|
18. |
董家鸿, 项灿宏. 肝门部胆管癌的精准外科手术治疗. 中华消化外科杂志, 2013, 12(3):170-173.
|
19. |
Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma:a histologic analysis of 62 resected cases. Ann Surg, 1998, 227(3):405-411.
|
20. |
Ercolani G, Zanello M, Grazi GL, et al. Changes in the surgical appr-oach to hilar cholangiocarcinoma during an 18-year period in a Wes-tern single center. J Hepatobiliary Pancreat Sci, 2010, 17(3):329-337.
|
21. |
Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg, 1990, 14(4):535-543.
|
22. |
Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilarcholan-giocarcinoma in the "new era":the Nagoya University experience. J Hepatobiliary Pancreat Sci, 2010, 17(4):449-454.
|
23. |
姜小清, 易滨, 罗祥基, 等. 肝门部胆管癌10年外科治疗经验.中华消化外科杂志, 2010, 9(3):180-182.
|
24. |
Abd ElWahab M, El Nakeeb A, El Hanafy E, et al. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma:A retrospective study of 5-year survivors. World J Gastrointest Surg, 2016, 8(6):436-443.
|
25. |
Juntermanns B, Fingas CD, Sotiropoulos GC, et al. Klatskin tumor:long-term survival following surgery. Chirurg, 2016, 87(6):514-519.
|